Topic
Diabetes Treatment
6 stories related to this topic, newest first.
nbcnews.comscience1 day ago
Study Finds Semaglutide Linked to 15% Lower Fracture Risk in Type 2 Diabetes Patients
A study of more than 59,000 adults with type 2 diabetes found that patients taking semaglutide recorded fewer bone fractures than those using other weight-loss drugs. Researchers presented the data at the Endocrine Society's annual meeting in Chicago.
thehindubusinessline.comscience15 days ago
Pfizer Reports Phase 2b Results for Monthly GLP-1 Drug Berobenatide
Pfizer's experimental GLP-1 receptor agonist berobenatide showed strong blood-sugar control and weight-loss effects in a Phase 2b trial. The company said the drug was generally well tolerated and supported further testing of once-monthly dosing.
FI
foxbusiness.combusiness34 days ago
Maryland Board Sets $274 Monthly Cap on Ozempic for State Purchases
The Maryland Prescription Drug Affordability Board voted to cap the price of Ozempic at $274 per 30-day supply for state and local government purchases starting January 2027. The limit is expected to save $5.8 million annually and follows a similar action taken by the board in re…
sciencealert.comscience44 days ago
Metformin Acts Primarily Through Gut Mitochondrial Complex I Inhibition
A study published in Nature Metabolism found that metformin, a widely prescribed drug for type 2 diabetes, lowers blood glucose mainly by inhibiting mitochondrial complex I in the intestinal epithelium rather than in the liver. The research used human metabolomic data and mouse g…
ER
vancouversun.comscience45 days ago
Health Canada Approves First Generic Versions of Diabetes Drug Ozempic
Health Canada approved the first generic version of Ozempic by Dr. Reddy's Laboratories on April 28 and cleared a second from Apotex, while reviewing seven others. The generics are available only in Canada. Novo Nordisk anticipates a low single-digit impact and is relying on savi…
Substrate placeholder — needs reviewbusiness69 days ago
Maryland Board Establishes $204 Monthly Cap on Jardiance for Public Purchases by 2027
The Maryland Prescription Drug Affordability Board has established an upper payment limit for Jardiance, a type 2 diabetes medicine, capping its price at $204 for a 30-day supply by January 2027. The board will oversee a process to lower costs for state and local governments. The…
ST